Conduit Pharmaceuticals (NASDAQ:CDT) said on Thursday that the company received formal notice from Nasdaq, stating that the company’s application to transfer the listing of its common stock to Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback